Microgen Scientific Industrial Company for Immunobiological Medicines   Report issue

For profit Phase 1 Phase 3
Founded: Moscow Russian Federation (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2012
NCT01511419
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Joint Stock Company Microgen, Russia | JSC "SIC "Microgen" | Microgen | Russia: Microgen Scientific Industrial Company for Immunobiological Medicines